Searcharxiv⌕ Search
Home/Archive/arXiv

arXiv · 0705.3188

A passivity-based stability criterion for a class of interconnected systems and applications to biochemical reaction networks

Murat Arcak·Eduardo D. Sontag
View original source ↗Read source document ↗Export metadata ↓

Abstract

This paper presents a stability test for a class of interconnected nonlinear systems motivated by biochemical reaction networks. One of the main results determines global asymptotic stability of the network from the diagonal stability of a "dissipativity matrix" which incorporates information about the passivity properties of the subsystems, the interconnection structure of the network, and the signs of the interconnection terms. This stability test encompasses the "secant criterion" for cyclic networks presented in our previous paper, and extends it to a general interconnection structure represented by a graph. A second main result allows one to accommodate state products. This extension makes the new stability criterion applicable to a broader class of models, even in the case of cyclic systems. The new stability test is illustrated on a mitogen activated protein kinase (MAPK) cascade model, and on a branched interconnection structure motivated by metabolic networks. Finally, another result addresses the robustness of stability in the presence of diffusion terms in a compartmental system made out of identical systems.

Explore related subjects

q-bio.QM

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Murat Arcak, Eduardo D. Sontag. 2007-05-22. A passivity-based stability criterion for a class of interconnected systems and applications to biochemical reaction networks. https://arxiv.org/abs/0705.3188

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

RetroTAC: Learning Route-Derived Synthetic Accessibility for PROTACs

Proteolysis-targeting chimeras (PROTACs) enable targeted protein degradation, expanding therapeutic opportunities beyond conventional inhibition. However, assembling their large, multifunctional structures creates synthetic challenges that hinder their discovery. Traditional synthetic-accessibility scores can overestimate this difficulty by penalizing PROTACs' molecular complexity while overlooking modular assembly from accessible building blocks. In contrast, retrosynthesis planning tools provide explicit routes but are computationally expensive, particularly for large molecules. Here, we introduce a human-interpretable, PROTAC-oriented route-derived score that rewards short synthetic depth and balanced joining of molecular fragments, and RetroTAC, a machine-learning surrogate that predicts this score directly from molecular structures. RetroTAC combines complementary models in an ensemble, achieving a root mean squared error of 0.13 and an $R^2$ of 0.65 on held-out molecules. We further evaluate its utility on PROTACs enumerated by recombining warheads, linkers, and E3-ligase ligands, followed by retrosynthetic planning and route analysis. Candidates selected for high predicted scores achieve a mean route-derived synthesizability of 0.73, compared with 0.31 for low-score candidates; 98.75% versus 51.00% are fully resolved under the tested search settings. These results support RetroTAC as a fast prioritization tool for virtual PROTAC libraries, connecting molecular screening with interpretable route characteristics while reserving explicit planning for selected candidates.

q-bio.QM↗
arXiv2026

Documenting Trofinetide Treatment Phenotypes in Rett Syndrome with a Dual-LLM Consensus Pipeline

Objective: Trofinetide, approved in 2023 as the first Rett syndrome treatment, lacks scalable real-world monitoring because chart review is labor-intensive. We developed a dual large language model (LLM) consensus pipeline to extract 18 treatment-response phenotypes, comprising 4 adverse effects, 13 Rett clinical features, and medication refusal, from clinical notes. Materials and Methods: We analyzed 26,763 notes from 108 patients with confirmed sustained trofinetide exposure at Texas Children's Hospital. The pipeline filters notes by keyword, classifies each through two LLMs requiring consensus, and aggregates a patient-by-timepoint matrix. Architecture and prompt were selected on a diarrhea development set, then frozen and applied to the other 17 phenotypes with the phenotype definition substituted, as an out-of-sample test. The reported prompt comparison scores 183 expert-labeled cells. Results: A prompt requiring diarrhea to be active and severe performed best (84.2 $\pm$ 0.0% accuracy; F1 = 0.674), 47 percentage points above regular-expression matching ($p < 0.0001$). Expert reviewers judged six of the pipeline's calls per phenotype, three positive and three negative, and agreed with 90.2% (92/102). The 13 Rett clinical features are manifestations of the disorder itself rather than adverse effects of trofinetide. Gross and fine motor impairment, language/communication, and stereotypy were documented present in 92-100% of patients at every visit. Discussion: In-context LLM extraction captured multi-domain treatment responses. The outcome is documented presence at each visit, not a direction-of-change judgment. Conclusion: Coupling in-context LLM reasoning with a consensus architecture offers a scalable alternative to keyword and regular-expression extraction for real-world evidence, adapting to new phenotypes and medications through configuration alone.

q-bio.QM↗
arXiv2026

Imaging-anchored multiomics in cardiovascular disease: integrating cardiac imaging, bulk, single-cell, and spatial transcriptomics

Cardiovascular disease arises from interactions between inherited risk, molecular programmes, and tissue-scale remodelling that are observed clinically through imaging. Cardiac MRI (CMR), computed tomography (CT), and echocardiography are integral to routine cardiovascular care, while bulk RNA sequencing, single-cell RNA sequencing, and spatial transcriptomics are providing increasingly detailed molecular characterization of cardiac tissue. Yet, these imaging and molecular data are still analysed in largely separate pipelines. This review examines joint representations that link cardiac imaging phenotypes to transcriptomic and spatially resolved molecular states. An imaging-anchored perspective is adopted in which echocardiography, CMR, and CT define a spatial phenotype of the heart, and bulk, single-cell and spatial transcriptomics provide cell-type- and location-specific molecular context. We define the representation requirements of each modality, compare multimodal fusion strategies, and synthesize integrative pipelines for radiogenomics, spatial alignment, and image-based gene-expression prediction, together with their validation requirements, limitations, and failure modes. Spatial multiomic maps of human myocardium and atherosclerotic plaque, together with single-cell, spatial, and multimodal medical foundation models, are advancing imaging-anchored multiomics; however, cost, scalability, and tissue availability remain substantial barriers to large-scale cardiovascular translation.

q-bio.QM↗